TFTC Consultant Urologists Tim Dudderidge and Raj Nigam are co-authors of a report published in Nature today based on an eight-year study led by Imperial College London
The key finding in a cohort of 335 radical prostatectomy patients and 501 focal therapy patients is “In patients with non-metastatic low- intermediate prostate cancer, oncological outcomes over 8 years were similar between focal therapy and radical prostatectomy”Read Nature magazine.
We understand that you may be surprised that you didn’t know focal therapy was a treatment option, and therefore are sceptical about it. We urge you to get in contact with us and we will answer any questions you may have on focal therapy and whether it is the best treatment option for you. If you would rather do your own research then there are many available resources on the internet.
At present, the most extensive and evidence-based study on the outcome of focal therapy being used to treat prostate cancer is the Multicentre Study of 5-year Outcomes, published in October, 2018.
Highlights from this study include:
It is important to note that as the study was conducted over a 5 year period it can only include the ‘medium term’ in its conclusion, as long term is defined as a 10 year span.
This study is the biggest of its kind and demonstrates why focal therapy should be a part of any treatment consideration process for early stage prostate cancer.
As a group of consultants we are passionate about all prostate cancer sufferers knowing about all of their treatment options.
Based upon the details that you know and can provide to us, we will send you a Plain English personalised preliminary suitability report for HIFU Focal Therapy treatment of your prostate cancer.
You can use the information we provide in your conversations with your existing NHS and/or private treatment consultant. Should you wish to talk with us further we would be grateful to help you, but there is absolutely no obligation for you to do so whatsoever.